Press Releases

February 22, 2013 Lupin Receives FDA Approval for New Drug Application for SUPRAX® Oral Suspension, 500 mg/5mL

January 31, 2013 Record Sales and Profits – Quarter III Results, FY 2012-13

November 20, 2012 Lupin launches Generic TRICOR® Tablets

October 30, 2012 Consistent Growth, Robust Profits Quarter II Results, FY 2013-14 Net Sales up 18%; EBITDA up 42%; Net profit up 40%

October 25, 2012 Lupin launches Generic Seasonale® Tablets; receives FDA approval

October 23, 2012 Record Sales & Profits Quarter II Results, FY 2012-13 Net Sales up 29%, EBITDA up 28%, PBT up 27%, PAT up 9%

October 22, 2012 Lupin Receives FDA Approval for its New Drug Application for Antara® Capsules

October 18, 2012 Lupin receives FDA approval for its Oral Contraceptive Kurvelo® Tablets; The Generic of Nordette® Tablets

October 17, 2012 Lupin receives FDA approval for Generic Avapro® Tablets